“Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-Small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?”. 2025. Canadian Oncology Today 2 (1): 13–17. https://doi.org/10.58931/cot.2025.2131.